Cancer Care in Crisis: How Subsidy Cuts Affected Immunotherapy Access for Patients With Small Cell Lung Cancer in Lebanon

Puntos clave

• Access to immunotherapy for small cell lung cancer has significantly declined due to subsidy cuts, leading to poorer patient outcomes.
• Around 60% of patients reported difficulties in obtaining needed immunotherapy treatments amid subsidies withdrawal.
• The observational analysis highlights how financial protection measures are essential to secure equitable cancer care in Lebanon's ongoing crisis.
• Urgent action is needed to address the financial barriers affecting cancer treatment access, especially under current economic constraints.